What does Theralase Technologies Inc. do?
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally. The company operates in two segments, Drug Division and Device…
What is Theralase Technologies Inc.'s P/E and P/B ratio?
Theralase Technologies Inc. has a P/E ratio of -20.0 and a P/B ratio of 9.08.
What is Theralase Technologies Inc.'s debt-to-equity ratio?
Theralase Technologies Inc. has a debt-to-equity ratio of 0.02.
How much does Theralase Technologies Inc. owe compared with what it owns?
Theralase Technologies Inc. owes C$0.16 for every C$1 it owns (balance sheet Jun 2026), which is low.
What is Theralase Technologies Inc.'s Positivity rank?
Theralase Technologies Inc. is ranked #10,831 of 12,739 companies globally and #1,317 of 1,841 in Canada on PositoAI, with a Positivity Score of 16,667.
Does Theralase Technologies Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Theralase Technologies Inc..
Where can I read the latest news about Theralase Technologies Inc.?
Recent headlines about Theralase Technologies Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Theralase Technologies Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Theralase Technologies Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.